Valine

Valine

SCHEMBL3486854

CC(C)[C@H](N)C(=O)O.CC(C)[C@H](N)C(=O)O.CC(C)[C@H](N)C(=O)O.C[C@H](N)C(=O)O.C[C@H](N)C(=O)O.C[C@H](N)C(=O)O

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 2/20 0.88
SLC1A3 P43003 2/20 0.44
SLC1A2 P43004 2/20 0.44
SLC1A1 P43005 2/20 0.44
TP53 P04637 1/20 0.40
DPP4 P27487 1/20 0.38
FAP Q12884 1/20 0.38
DPP8 Q6V1X1 1/20 0.38
DPP9 Q86TI2 1/20 0.38
DPP7 Q9UHL4 1/20 0.38
LAP3 P28838 1/20 0.38
USP2 O75604 1/20 0.36
SLCO1B1 Q9Y6L6 1/20 0.36
LTA4H P09960 1/20 0.35
GABRP O00591 3/20 0.35
GABRD O14764 3/20 0.35
GABRA1 P14867 3/20 0.35
GABRB1 P18505 3/20 0.35
GABRG2 P18507 3/20 0.35
GABRB3 P28472 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Valine SCHEMBL229819 1.00 SLC7A5 (0.88) SLC7A5SLC1A3SLC1A2SLC1A1TP53
Valine SCHEMBL10710877 1.00 SLC7A5 (0.88) SLC7A5SLC1A3SLC1A2SLC1A1TP53
Valine SCHEMBL3076649 1.00 SLC7A5 (0.88) SLC7A5SLC1A3SLC1A2SLC1A1TP53
Valine SCHEMBL2017287 1.00 SLC7A5 (0.88) SLC7A5SLC1A3SLC1A2SLC1A1TP53
Valine SCHEMBL229818 1.00 SLC7A5 (0.88) SLC7A5SLC1A3SLC1A2SLC1A1TP53
Valine SCHEMBL17113862 1.00 SLC7A5 (0.88) SLC7A5SLC1A3SLC1A2SLC1A1TP53
Valine SCHEMBL27597271 0.95 SLC7A5 (0.79) SLC7A5SLC1A3SLC1A2SLC1A1TP53
Valine SCHEMBL1813972 0.94 SLC7A5 (1.00) SLC7A5SLC1A3SLC1A2SLC1A1TP53
Valine SCHEMBL8516 0.94
Valine SCHEMBL288203 0.94 SLC7A5 (1.00) SLC7A5SLC1A3SLC1A2SLC1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4732841-A1 FOAM SCLEROSANT COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF Jenkem Technology Co., Ltd. (Beijing) (CN) 2026-04-29 EP claimed
EP-3822299-B1 BIO-BASED POLYCARBONATE ESTER RESIN FOR EYEGLASS FRAME SK CHEMICALS CO LTD (KR) 2026-02-18 EP claimed
US-12391795-B2 Polymerizable composition, and copolycarbonate ester and method for producing same SK CHEMICALS CO., LTD. (KR) 2025-08-19 US claimed
US-12269921-B2 Polycarbonate copolymer, method for preparing same, and composition comprising same Hanwha Solutions Corporation (KR) 2025-04-08 US claimed
EP-4502004-A1 POLYCARBONATE COPOLYMER, METHOD FOR PREPARING SAME, AND COMPOSITION COMPRISING SAME Hanwha Solutions Corporation (KR) 2025-02-05 EP claimed
US-20250019495-A1 POLYCARBONATE COPOLYMER, METHOD FOR PREPARING SAME, AND COMPOSITION COMPRISING SAME Hanwha Solutions Corporation (KR) 2025-01-16 US claimed
US-12162982-B2 Highly bio-based polycarbonate ester and method for producing same SK CHEMICALS CO., LTD. (KR) 2024-12-10 US claimed
EP-3872112-B1 HIGHLY BIO-BASED POLYCARBONATE ESTER AND METHOD FOR PRODUCING SAME SK CHEMICALS CO LTD (KR) 2023-07-19 EP claimed
WO-2023018805-A1 METHODS AND RELATED ASPECTS OF DETECTING AND PURIFYING INFLUENZA NEURAMINIDASE SANOFI PASTEUR INC. (US) 2023-02-16 WO claimed
US-11479640-B2 Bio-based polycarbonate ester resin for eyeglass frame SK CHEMICALS CO., LTD. (KR) 2022-10-25 US claimed
EP-3822299-A1 BIO-BASED POLYCARBONATE ESTER RESIN FOR EYEGLASS FRAME SK Chemicals Co., Ltd. (KR) 2021-05-19 EP claimed
WO-2020085686-A1 POLYMERIZABLE COMPOSITION, AND COPOLYCARBONATE ESTER AND METHOD FOR PRODUCING SAME 에스케이케미칼 주식회사 2020-04-30 WO claimed
WO-2020085662-A1 HIGHLY BIO-BASED POLYCARBONATE ESTER AND METHOD FOR PRODUCING SAME 에스케이케미칼 주식회사 2020-04-30 WO claimed
US-9085604-B2 Antiproliferative factor and methods of use UNIVERSITY OF MARYLAND, BALTIMORE (US) 2015-07-21 US claimed
US-8303685-B2 Regeneration of acid gas-containing treatment fluids DOW GLOBAL TECHNOLOGIES LLC (US) 2012-11-06 US claimed
EP-2121025-A2 METHODS AND COMPOSITIONS FOR THE DELIVERY OF A THERAPEUTIC AGENT Hananja Ehf (IS) 2009-11-25 EP claimed
WO-2008089426-A2 METHODS AND COMPOSITIONS FOR THE DELIVERY OF A THERAPEUTIC AGENT HANANJA EHF (IS) 2008-07-24 WO claimed
US-20060178259-A1 Regeneration of acid gas-containing treatment fluids DOW GLOBAL TECHNOLOGIES LLC 2006-08-10 US claimed
EP-1648590-A1 REGENERATION OF ACID GAS-CONTAINING TREATMENT FLUIDS DOW GLOBAL TECHNOLOGIES INC. (US) 2006-04-26 EP claimed
WO-2005009592-A1 REGENERATION OF ACID GAS-CONTAINING TREATMENT FLUIDS DOW GLOBAL TECHNOLOGIES INC. (US) 2005-02-03 WO claimed